Randomized phase II trial of S-1 plus docetaxel combination versus single-agent docetaxel in platinum-pretreated patients with non-small-cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 08 Jan 2015
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 06 Jun 2009 Results have been reported at the 45th Annual Meeting of the American Society of Clinical Oncology.
- 05 Jun 2009 New trial record.